Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials for the treatment of glabellar (frown) lines and cervical dystonia; is in phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. It is also developing DaxibotulinumtoxinA in preclinical trial for the treatment of migraine, as well as a topical program for various indications; and OnabotulinumtoxinA, a biosimilar to BOTOX. The company has a collaboration and license agreement with Viatris Inc. to develop, manufacture, and commercialize onabotulinumtoxinA. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Revance Therapeutics Inc..
Revance Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Revance Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Revance Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Revance Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Revance Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Revance Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Revance Therapeutics Inc.- Key Facts
2.2 Revance Therapeutics Inc.- Geographic Locations
2.3 Revance Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Revance Therapeutics Inc.- Business Divisions
2.5 Revance Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Revance Therapeutics Inc. Strategic Analysis Review
3.1 Revance Therapeutics Inc.- Key Strategies
3.2 Revance Therapeutics Inc.- Company Outlook Statement
3.3 Revance Therapeutics Inc.- SWOT Analysis
3.3.1 Revance Therapeutics Inc.- Key Strengths
3.3.2 Revance Therapeutics Inc.- Key Weaknesses
3.3.3 Revance Therapeutics Inc.- Potential Opportunities
3.3.4 Revance Therapeutics Inc.- Potential Threats
3.4 Revance Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Revance Therapeutics Inc.- Business Overview
4.2 Revance Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Revance Therapeutics Inc.- Key Products
5.2 Revance Therapeutics Inc.- Key Service Areas
5.3 Revance Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Revance Therapeutics Inc.- Company History
6.2 Revance Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Revance Therapeutics Inc.- Income Statements
7.2 Revance Therapeutics Inc.- Balance Sheet
7.3 Revance Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Revance Therapeutics Inc.- Direct Competitors
8.2 Revance Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Revance Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Revance Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!